论文部分内容阅读
目的:评价南京地区医院抗癫痫药的应用现状及趋势。方法:对南京地区34家医院2012-2014年抗癫痫药的品种、用量、销售金额、用药频度等进行回顾性统计、分析。结果:南京地区抗癫痫药销售金额逐年增加。各年度新型抗癫痫药销售金额均占抗癫痫药总销售金额的六成左右,DDDs所占比例从2012年的35.43%增长至2014年的45.53%。金额排序中丙戊酸钠各年度一直占据36%左右,稳居第一;新型抗癫痫药加巴喷丁、左乙拉西坦、奥卡西平销售金额逐年大幅增加,苯妥英钠、托吡酯年销售金额略有起伏。DDDs排序中丙戊酸钠以绝对优势稳居第一;新型抗癫痫药除托吡酯外用药频度均呈逐年增加趋势,而传统AEDs除丙戊酸钠外均逐年降低。结论:南京地区抗癫痫药丙戊酸钠、奥卡西平选用倾向大,传统抗癫痫药丙戊酸钠在抗癫痫药中仍占据重要地位,新型抗癫痫药如奥卡西平、左乙拉西坦、拉莫三嗪、加巴喷丁等不良反应、耐受性、对肝药酶的影响性等优于传统抗癫痫药,市场前景良好。
Objective: To evaluate the status quo and trend of anti-epileptic drugs in Nanjing area hospitals. Methods: Retrospective statistics and analysis were conducted on the types, amount, sales amount and frequency of antiepileptic drugs in 34 hospitals in Nanjing in 2012-2014. Results: The sales amount of antiepileptic drugs in Nanjing increased year by year. The annual sales of new antiepileptic drugs accounted for about 60% of the total sales of antiepileptic drugs. The proportion of DDDs increased from 35.43% in 2012 to 45.53% in 2014. The amount of sodium valproate in the amount of each year accounted for about 36%, ranking first; new antiepileptic drugs gabapentin, levetiracetam, oxcarbazepine sales increased significantly each year, phenytoin sodium, topiramate annual sales slightly ups and downs. DDV ranked the highest in the absolute superiority of sodium valproate in the first; new anti-epileptic drugs in addition to topiramate outside the frequency showed a trend of increasing year by year, while the traditional AEDs except sodium valproate are decreased year by year. CONCLUSIONS: Antiepileptic drugs sodium valproate and oxcarbazepine in Nanjing have a high propensity to use. The traditional anti-epileptic drug valproate still plays an important role in antiepileptic drugs. New antiepileptic drugs such as oxcarbazepine, Tan, lamotrigine, gabapentin and other adverse reactions, tolerance, the impact of liver enzymes and other advantages over traditional antiepileptic drugs, the market prospects are good.